AIDS Action Weekly UpdateMay 9, 1997 Welcome to AIDS Action Council's Weekly Washington Update, an on-line
newsletter for Handsnet subscribers that reviews what is happening in Washington
on AIDS policy issues each week. If you have any comments or questions, please
feel free to contact us at the e-mail address listed below.
Balanced Budget Details As budget negotiations continue Congressional leaders are getting ready to begin crafting their annual Budget Resolution. Hoping to have completed work on the Resolution, a blueprint which provides general guidance and overall funding levels to the 13 appropriation subcommittees, by the Memorial Day recess (beginning on May 22), the Resolution will contain many of the elements of the budget agreement announced last week. The agreement included over $335 billion in spending cuts. $200 billion in cuts to entitlement programs include deep cuts in Medicare ($115 billion) and $15-17 billion in Medicaid (much of it coming from Disproportionate Share Hospital (DSH) payments. Although the per-capita-cap proposal was dropped from the agreement, many people living with HIV/AIDS rely on DSH for their care, and as people are living longer, more people living with HIV/AIDS rely on Medicare for their health care also. The agreement also calls for $61 billion in cuts to domestic discretionary programs over the next five years which include programs for people living with HIV/AIDS like Ryan White and HOPWA. Automatic Continuing Resolution Remains The Coburn Bill Slowly Gains Support The Coburn Bill has gained additional cosponsors bringing the total to 88. Two members of the House have officially come off the bill, Representatives Brian Bilbray (R-CA) and Jim Gibbons (R-NV), with about a dozen more who are reconsidering their position. Although support is slow, strong opposition must continue to be voiced. While it appears unlikely that the bill will pass as a whole, there is a danger of individual provisions of the bill being enacted by getting attached to appropriations or authorization bills. The appropriations process is picking up speed, offering more opportunity for provisions to be taken out and attached to other legislation. AIDS advocates are encouraged to contact their representatives and tell them to continue to oppose the bill and object to any individual provisions being attached to funding bills. Bipartisan Support Letters For Increased HIV/AIDS Funding Two bipartisan efforts began on Capitol Hill asking Members to sign-on to letters urging the Chairmen of both the House Labor-HHS-Education (L/HHS) and Veterans Affairs-Housing and Urban Development (VA/HUD) Appropriations Subcommittees for increased funding for federal AIDS programs. The letter to John Porter (R-IL), chair of the L/HHS subcommittee, originally sponsored by Republicans Connie Morella (MD), Christopher Shays (CT), Rick Lazio (NY), James Leach (IA), and Mark Foley (FL) and Democrats Barbara Kennelly (CT), Henry Waxman (CA), Maxine Waters (CA), Nydia Velazquez (NY), and William Delahunt (MA) urge Mr. Porter to increase funding for HIV/AIDS prevention, care, and research programs. While citing the amounts needed by these programs, the letter urges him to provide increases above the Administration's request. In a similar letter to Jerry Lewis (R-CA), original sponsors Representative Jerrold Nadler (D-NY) and Connie Morella (R-MD) urge the chairman to seek increases for the Housing Opportunities for People With AIDS (HOPWA) program over what the president had earlier requested. Currently, 63 Representatives have signed onto the Housing letter. AIDS advocates should encourage their representatives to sign on to these letters. Ask your Representative to contact Cindy Hall (202-225-4341) or Mark Agrast (202-225-3111) before May 21 in regards to the L/HHS letter to Porter and Cindy Hall and Zachary Katznelson (202-225-5635) in regards to the Housing letter to Lewis. Workshop Evaluates Antiretroviral Therapy In Perinatal Transmission The Antiretroviral Therapy to Reduce the Risk of Perinatal Transmission Workshop, sponsored by the National Institutes of Health (NIH), was held to review and update the 1994 recommendations on the use of AZT to reduce the risk of perinatal HIV transmission. It is recognized that there are two distinct issues involved in antiretroviral treatment for pregnant women: 1) the use of antiretrovirals for maternal health indications, and 2) the use of antiretroviral for reducing the perinatal HIV transmission risk. The main focus of the workshop will be the use of antiretroviral drugs for the reduction of perinatal transmission. The Public Health Service has recently developed guidelines which focus on antiretroviral therapy for maternal health indications. These guidelines indicate that pregnancy should not preclude the use of optimal HIV therapeutic treatments. A diverse group of participants will be attending, including women who participated in the 076 studies as part of the review panel.
This article was provided by AIDS Action Council. It is a part of the publication AIDS Action Weekly Update. |